- Page 1: Novel Clinical and Etiopathogenetic
- Page 7 and 8: Table of contents o LIST OF ABBREVI
- Page 9: Publication 8 Low serum vitamin K i
- Page 12: TE tropoelastin TGF-β transforming
- Page 16 and 17: the disorder with the xanthomatoses
- Page 18 and 19: completeness. Non-Mendelian inherit
- Page 20 and 21: to have an effect on the expression
- Page 22 and 23: Figure 2 Atomic force microscopic i
- Page 24 and 25: The metabolic turnover of elastin -
- Page 26 and 27: McKusick’s categories became appa
- Page 28 and 29: such as stronger polyanion properti
- Page 30 and 31: Other negative regulators of uncont
- Page 32 and 33: called reticular layer of the derm,
- Page 34 and 35: the epidermis - [82-89] a reticulat
- Page 36 and 37: Figure 10 Graphic representation of
- Page 38 and 39: their central sight. It is however
- Page 40 and 41: The histological structure of the h
- Page 42 and 43: damage of submucosal arteries have
- Page 44 and 45: Figure 15 Characteristics of the hu
- Page 46 and 47: gene [215]. This interaction is sug
- Page 48 and 49: Le Saux et al. addressed this hypot
- Page 50 and 51: 1.3.7 Animal models An animal model
- Page 52 and 53:
inflammatory drugs should be avoide
- Page 54 and 55:
In our PXE clinic, all patients are
- Page 56 and 57:
energy into an electrical signal, a
- Page 58 and 59:
c/ pattern ERG (PERG) PERG is a ret
- Page 60 and 61:
2.2.2.2 Mutation detection To deter
- Page 62 and 63:
a/ general principles and terminolo
- Page 65 and 66:
Chapter 3 Results o “Une accumula
- Page 67 and 68:
MUTATION IN BRIEF Received 5 May 20
- Page 69 and 70:
Clinical evaluation protocol 55 Nov
- Page 71 and 72:
57 Novel Clinico-molecular Insights
- Page 73 and 74:
59 Novel Clinico-molecular Insights
- Page 75 and 76:
61 Novel Clinico-molecular Insights
- Page 77 and 78:
63 Novel Clinico-molecular Insights
- Page 79:
65 Novel Clinico-molecular Insights
- Page 83 and 84:
ORIGINAL ARTICLE Mutation detection
- Page 85 and 86:
ABCC6 mutations in pseudoxanthoma e
- Page 87 and 88:
ABCC6 mutations in pseudoxanthoma e
- Page 89 and 90:
ABCC6 mutations in pseudoxanthoma e
- Page 91:
3.2 Innovative clinical aspects of
- Page 94 and 95:
obtained from all patients and the
- Page 96 and 97:
As serum tests for liver and kidney
- Page 99:
Publication 4 Pseudoxanthoma elasti
- Page 102 and 103:
IOVS, September 2007, Vol. 48, No.
- Page 104 and 105:
IOVS, September 2007, Vol. 48, No.
- Page 106 and 107:
IOVS, September 2007, Vol. 48, No.
- Page 109:
Publication 5 Added value of infrar
- Page 112 and 113:
Abstract Purpose: Pseudoxanthoma El
- Page 114 and 115:
Patients and Methods Twenty-two pat
- Page 116 and 117:
Peau d'orange, which, according to
- Page 118 and 119:
Discussion Visualizing the PXE reti
- Page 120 and 121:
3. Vanakker OM, Leroy BP, Coucke PJ
- Page 122 and 123:
Figures 108
- Page 125:
Publication 6 Heterozygous ABCC6 mu
- Page 128 and 129:
Abstract Evidence is emerging that
- Page 130 and 131:
Baseline demographic data (age, sex
- Page 132 and 133:
Pat. S E X Current age (yrs) Stroke
- Page 134 and 135:
providing a basis for future studie
- Page 137:
3.3 Identification and etiopathogen
- Page 140 and 141:
OM Vanakker et al. PXE-Like Disorde
- Page 142 and 143:
OM Vanakker et al. PXE-Like Disorde
- Page 144 and 145:
OM Vanakker et al. PXE-Like Disorde
- Page 147:
Publication 8 Low serum vitamin K i
- Page 150 and 151:
Abstract Soft-tissue mineralization
- Page 152 and 153:
VKORC1 mutations - which both have
- Page 154 and 155:
Results A. PXE-like syndrome patien
- Page 156 and 157:
these findings are the direct conse
- Page 158 and 159:
From our findings, we can conclude
- Page 160 and 161:
26. Schurgers LJ, Geleijense J, Gro
- Page 162 and 163:
Figure 2 IHC staining results for c
- Page 164 and 165:
Figure 4 Transmission electron micr
- Page 167:
Publication 9 An atypical case of p
- Page 170 and 171:
Abstract In this case report, a pat
- Page 172 and 173:
Case report and discussion A Caucas
- Page 174 and 175:
like patients - presenting with ext
- Page 176 and 177:
Figures Figure 1 Phenotypic charact
- Page 178 and 179:
Figure 3 Immunohistochemical staini
- Page 180 and 181:
the etiopathogenesis of which lead
- Page 182 and 183:
4.1.2 Genotype-phenotype correlatio
- Page 184 and 185:
procedure. Unfortunately, the histo
- Page 186 and 187:
Peau d’orange could be observed i
- Page 188 and 189:
a tool for molecular screening. The
- Page 190 and 191:
angioid streaks in carriers, althou
- Page 192 and 193:
causal genetic factor in these pati
- Page 194 and 195:
subtle differences in fetuin-A stai
- Page 196 and 197:
3/ Why are clotting abnormalities a
- Page 198 and 199:
ongoing or being designed for the n
- Page 201 and 202:
Summary o o “If others can see it
- Page 203 and 204:
Samenvatting o “Dit Florentijnse
- Page 205 and 206:
Résumé o “Le fils d’un eunuqu
- Page 207 and 208:
References o 1. Rigal, D., Observat
- Page 209 and 210:
47. Pasquali Ronchetti, I., et al.,
- Page 211 and 212:
92. Akar, A., et al., Multiple kera
- Page 213 and 214:
139. van den Berg, J.S., et al., Pr
- Page 215 and 216:
186. Lao, T.T., B.N. Walters, and M
- Page 217 and 218:
227. Miksch, S., et al., Molecular
- Page 219 and 220:
272. Aessopos, A., D. Farmakis, and
- Page 221 and 222:
316. Arrigo, T., et al., Testicular
- Page 223 and 224:
365. Aessopos, A., et al., Pseudoxa
- Page 225:
412. Worcester, E.M., et al., The e
- Page 229 and 230:
Curriculum Vitae o o “It does tel
- Page 231 and 232:
7/ O.M. Vanakker, B.P. Leroy, P.Cou
- Page 233 and 234:
14/ O.M. Vanakker, L. Martin, D. Gh
- Page 235 and 236:
clotting deficiency represents a no
- Page 237 and 238:
Dankwoord o 223 Waar is de weg ? Er
- Page 239 and 240:
alhoewel ik moet zeggen - ik heb je